Cello Health

Through its distinct capabilities, Cello Health is able to offer:

Business Insights and Analytics

Our Insight team applies rigorous analysis and expert interpretation in order to provide strategic recommendations

Strategic and Scientific Consulting

Our Consulting team help solve complex scientific and commercial challenges throughout the product lifecycle

Scientific and Creative Communications 

Our Communications team care passionately about the science and making evidence matter across the entire healthcare spectrum

Breaking Blue Research Joins Cello Health Insight

We’re delighted to announce that our sister agency Breaking Blue Research is formally joining Cello Health Insight

Cello Health Acquire ISS

Acquisition further strengthens technical advisory services in US

Cello Health launches ‘Cello Health GmbH’ with new Berlin office and appointment of two regional directors to lead the Business Insights and Analytics division in Germany.

London, July 08, 2019 Cello Health GmbH opens in Berlin with its Business Insights and Analytics division, Cello Health Insight, appointing two regional directors: Heike Tombrink – Regional Director, Head of Cello Health Insight Germany, and Matthias Heurich – Regional Director, supporting Digital Innovation.

Cello Health Insight wins EphMRA’s 2019 Market Research Excellence Award for 'Business Impact through Innovation'

Cello Health Insight in partnership with Janssen Pharmaceuticals has won EphMRA’s 2019 Market Research Excellence Award for 'Business Impact through Innovation'.

Cello Health Launches New Social Insight & Analytics Business

Cello Health Logic offers pharmaceutical companies the ability to make sense of healthcare social media conversations and deliver actionable insights.

Cello Health Communications Accelerates its Digital Offering with New Leadership Appointments

Rick Lang and Craig Lipski join the organization in senior digital roles

Duncan Munro joins Cello Health Insight as Joint Head of ‘IQ’ Practice

Supporting quantitative team’s continued growth, bringing specialist advanced analytics, methodological and technical expertise.

Maria Eletskaya joins Cello Health Insight

Bolstering senior team for expanding 'IQ' Quantitative practice

Cello Health appoints health economics and market access expert in the United States

Doctors Embracing Digital Technology – But Are Reluctant To Prescribe Apps And Wearables For Patients

Face-to-face communication still biggest influence on prescribing behaviour, says new report

Cello Health Launches ‘Fresh Thinking’ App To Deliver Tailored Thought Leadership Direct To Mobile Devices

Cello Health has launched a new smartphone and tablet app to enable pharma and healthcare industry professionals to receive thought leadership pieces, comments and insight on topics directly relevant to them as individuals.

Researchers Must Be ‘Digital Savvy’ – But Not View Technology As A Panacea, Says Newly-Promoted Digital Expert

Healthcare market researchers will increasingly need to be ‘digital savvy’ and familiar with the full array of digital methodologies, but these should be viewed as complementary to traditional methods, not as a low-cost replacement for them – that is the view of newly-promoted Digital Product Manager at Cello Health Insight, Peter Furness.

Cello Health BioConsulting Appoints Senior Pharma Marketer As President

Cello Health BioConsulting, the newly-formed strategic management consulting firm focusing on pharmaceuticals, biotechnology and medical device companies in the United States, has announced the appointment of Jim Hall as President.

Experienced Healthcare Marketer Gareth Thurston, joins Cello Health Consulting

Specialist healthcare strategic marketing consultancy Cello Health Consulting has appointed experienced pharmaceutical marketing professional Gareth Thurston as a Consultant.

Cello Health BioConsulting adds another member to its senior team

Cello Health BioConsulting, the newly-formed strategic management consulting firm focusing on pharmaceuticals, biotechnology and medical device companies in the United States, has announced the appointment of James McDermott as Vice-President.

NEW APPOINTMENTS AND PROMOTION SIGNAL EXPANSION OF CELLO HEALTH INSIGHT QUANTITATIVE RESEARCH TEAM

Healthcare market research agency Cello Health Insight has announced the appointment of a Senior Methodologist in its quantitative research ‘IQ’ team, reflecting growth in demand in this area across the firm’s range of healthcare and pharmaceutical clients.

TWO SENIOR APPOINTMENTS FOR CELLO HEALTH BIOCONSULTING

Cello Health BioConsulting, the newly-formed strategic management consulting firm focusing on pharmaceuticals, biotechnology and medical device companies in the United States, has announced the appointment of Philip Vorhies and Mark Kasakevich as Vice-Presidents.

NEW SENIOR CONSULTANT FOR CELLO HEALTH CONSULTING

Specialist healthcare strategic marketing consultancy Cello Health Consulting has appointed senior marketing professional Robert Stringer as Senior Consultant.

CELLO HEALTH ANNOUNCES THE FORMATION OF CELLO HEALTH BIOCONSULTING IN THE US

Cello Health announces the formation of Cello Health BioConsulting in the US. Cello Health BioConsulting is a Strategic Management Consulting Firm focusing on Pharmaceuticals, Biotechnology and Medical Device companies in the United States. Cello Health BioConsulting will offer a unique set of services that focus on early product development, commercialization and business development support for small and mid-cap companies.

SENIOR PHARMA MARKETER JOINS CELLO HEALTH CONSULTING

Specialist healthcare strategic marketing consultancy Cello Health Consulting has appointed experienced pharma marketer Jon Gilbert as Senior Consultant.

Managing value: Why early asset development and commercialization is important

Realising the full value of your asset – clinically and commercially – means thinking beyond the pure scientific value, even at the very early stages of development.

Optimising market research data in rare disease

Helping to provide powerful insights into the burden of disease and the patient-caregiver experience.

Strategy - It's All About Choices

If you are entirely comfortable about the decisions you have made about the future, then there is a very good chance that your strategy is not a good one.

Use digital to maximise the value of sales meetings

Doctors are becoming increasingly tech-savvy, but still want face-to-face interactions with reps. Think about how technology can be applied to enhance these meetings, rather than deploying tech for tech’s sake, urges Paul Mannu.

The Seven Cs Of Cross-Functional Brand Planning

As more and more organisations have moved to cross-functional and cross-regional involvement in the development of their strategic and operational brand plans, the result has been greater engagement and alignment, with richer outputs – but this approach comes with significant challenges. Jon Bircher distils his experience, learnings and observations about getting the most out of cross-functional teams in the process of brand planning into seven recommendations.

The Journey to excellence

Over the last 20 years much has changed in healthcare delivery. The autonomy of choice of healthcare practitioners has been constrained as individual healthcare systems come to terms with increasing patient expectations, the availability of more effective but also more expensive treatments, an increasing demand for healthcare from increasing and ageing populations plus finite resources to meet these demands. With those market, customer and competitive landscape changes have come increasing challenges for a marketing organisation such as multiple stakeholders, demands for more evidence of cost-effective outcome, smaller differentials between alternative treatment options to name but a few. Paul Stuart-Kregor looks at the changes in marketing over the last 20 years and discusses how responding effectively to customer need should be at the heart of what every marketer does - focussing on outcome/result not input/effort to ensure we are effective, as commercially we are not rewarded for effort but result.

Pragmatic Digital Health

At the beginning of 2015, we looked into our crystal ball and identified five areas where technology would have an impact on the world of healthcare: technology partnerships; compliance apps; artificial intelligence; the increased use of 3D printing; and finally, somewhat most ambitiously, the bionic person. Several months on, Paul Mannu looks at how those predictions have panned out.

Organisational Memory

In a knowledge-based industry with high labour mobility, retaining that knowledge within an organisation during a drug’s lifecycle can be tricky. If we undervalue the knowledge, experience and marketing understanding which is gathered over time within our organisations, then we risk seeing those valuable assets simply walk out of the door with each individual moving on to pastures new. Isaac Batley suggests five steps to improving that ‘organisational memory’.

Thoughts on the intersection between technology and psychology

Paul Mannu - Master Practitioner, Behavioural Insights at Cello Health Insight gives us his succinct thoughts on the intersection between technology and psychology

Learning to listen - Examining the opportunities and challenges of using conversations on social media for Pharma brands

The world in which we do business has markedly changed since 2008, which has helped to increase the push towards the ‘digitisation’ of marketing communications’ channels, This feature explores the merits of effective social media listening, but cautions that not all conversations are equal.

The changing face of primary care in the UK

The complexion of Britain’s primary care providers has changed beyond recognition in recent years. This is leading to significant consequences for the way pharma interacts with them, says Paul Mannu.

It's time to change the conversation

The world of drug promotion has changed. It has ceased to be a simple matter of detailing to physicians and an occasional pharmacist; it has evolved into a much more sophisticated activity, supported by new technology and much more targeted. However do we use these new technologies to do the same old things or do we use them instead to change our approach to promotional activities?

The future of oncology market research

Greater differentiation of diagnoses and treatments in cancer means market researchers are facing new challenges in dealing with very small numbers of patients sensitively while gaining the insights that pharma companies need to design appropriate tailored support. Jane Barrett explains how to balance these demands.

How to make the most of online communities

Jenny Fletcher explains some ways to gain the most from an online community, through treating participants as individuals and tailoring research methods to their preferences

Preparing for biopharma marketing in 2020 and beyond - Who is the marketer of the future?

Pharma operates in a constantly evolving landscape yet many companies persist with skills/competency surveys of their people and processes which define their capability level in terms of the last 12 months to today. This provides a healthy base-line, but does little to prepare for the future. ReadRussell Powter’s recently published feature published in the June issue of PM Europe to find out how can we help companies identify where they need to invest in order to prepare ahead and ensure their marketing teams are fit for purpose in the future.

Driving Innovation And Value Creation Through A Customer-Centric Culture

Pharma must seriously look at other sectors to learn how to deliver true customer centric thinking relevant to pharma, says Russell Powter.

MORE MONEY FOR THE NHS – BUT IS THIS THE ANSWER?

Paul Mannu of Cello Health Insight says that politicians opening their pre-election cheque books can’t put the NHS where it needs to be – but pharma can play a major role in doing so.

Antibiotic Resistance: Alarm bells ring louder than ever

Though international focus is turning to antimicrobial resistance and incentives are being provided for research into new drugs, there are many hurdles to be jumped before a blockbuster can be discovered and developed in this challenging field.